Table 1 Dataset summary statistics
From: Personalized hypertension treatment recommendations by a data-driven model
Features | All patients N = 42,792 |
|---|---|
Mean age* | 60.93 |
Mean SBP (mmHg)* | 136.11 |
Female | 22,445 (52.45% of N) |
Male | 20,345 (47.54% of N) |
White Patients | 11,170 (26.10% of N) |
Black Patients | 21,260 (49.68% of N) |
Hispanic Patients | 3,946 (9.22% of N) |
Ever Cigarette User | 11,790 (27.55% of N) |
Hypertension drugs used†| All Patient Visits (M = 432,096) |
Calcium Channel Blockers (CCBs) | 115,450 (26.72% of M) |
Thiazide diuretics | 92,290 (21.36% of M) |
Angiotensin II Receptor Blockers (ARBs) | 43,072 (9.97% of M) |
ACE Inhibitors (ACEi) | 129,800 (30.04% of M) |
Beta-Blockers | 86,171 (19.94% of M) |
Loop diuretics | 35,316 (8.17% of M) |
Mineralocorticoid Receptor Antagonists (MRAs) | 9,550 (2.21% of M) |